Business Description
Rapid Dose Therapeutics Corp
NAICS : 325410
SIC : 3741
ISIN : CA75339A1012
Description
Rapid Dose Therapeutics Corp provides proprietary drug delivery technologies designed to improve outcomes and quality of lives. The Company has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. The company's operations are in Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | -2.19 | |||||
Debt-to-Equity | -0.72 | |||||
Debt-to-EBITDA | -3.1 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -23.9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 44.2 | |||||
3-Year EBITDA Growth Rate | 24.6 | |||||
3-Year EPS without NRI Growth Rate | 9.1 | |||||
3-Year FCF Growth Rate | 37 | |||||
3-Year Book Growth Rate | -26.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 83.7 | |||||
9-Day RSI | 73.76 | |||||
14-Day RSI | 67.14 | |||||
3-1 Month Momentum % | -85.13 | |||||
6-1 Month Momentum % | -85.33 | |||||
12-1 Month Momentum % | -90.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.04 | |||||
Quick Ratio | 0.02 | |||||
Days Inventory | 53.65 | |||||
Days Sales Outstanding | 34.11 | |||||
Days Payable | 499.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.3 | |||||
Shareholder Yield % | -19.94 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 49.14 | |||||
Operating Margin % | -78.26 | |||||
Net Margin % | -122.21 | |||||
EBITDA Margin % | -59.77 | |||||
FCF Margin % | -10.08 | |||||
OCF Margin % | -12.72 | |||||
ROA % | -100.02 | |||||
ROIC % | -35.92 | |||||
3-Year ROIIC % | 44.53 | |||||
ROC (Joel Greenblatt) % | -79.87 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 6.15 | |||||
EV-to-EBIT | -7.83 | |||||
EV-to-EBITDA | -10.25 | |||||
EV-to-Revenue | 6.11 | |||||
EV-to-FCF | -60.66 | |||||
Price-to-GF-Value | 0.34 | |||||
Earnings Yield (Greenblatt) % | -12.77 | |||||
FCF Yield % | -2.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RDTCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rapid Dose Therapeutics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.004 | ||
| EPS (TTM) ($) | -0.036 | ||
| Beta | 17.5035 | ||
| 3-Year Sharpe Ratio | 0.7 | ||
| 3-Year Sortino Ratio | 16.57 | ||
| Volatility % | 114.01 | ||
| 14-Day RSI | 67.14 | ||
| 14-Day ATR ($) | 0.004219 | ||
| 20-Day SMA ($) | 0.062162 | ||
| 12-1 Month Momentum % | -90.52 | ||
| 52-Week Range ($) | 0.006 - 0.15 | ||
| Shares Outstanding (Mil) | 135.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rapid Dose Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rapid Dose Therapeutics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rapid Dose Therapeutics Corp Frequently Asked Questions
What is Rapid Dose Therapeutics Corp(RDTCF)'s stock price today?
The current price of RDTCF is $0.09. The 52 week high of RDTCF is $0.15 and 52 week low is $0.01.
When is next earnings date of Rapid Dose Therapeutics Corp(RDTCF)?
The next earnings date of Rapid Dose Therapeutics Corp(RDTCF) is .
Does Rapid Dose Therapeutics Corp(RDTCF) pay dividends? If so, how much?
Rapid Dose Therapeutics Corp(RDTCF) does not pay dividend.
Guru Commentaries on OTCPK:RDTCF
No articles.
Press Release
Articles on Rapid Dose Therapeutics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers